KIT Inhibitor CDX-0159 Shows Potential As Therapy for Mast Cell Diseases
Celldex Therapeutics’ CDX-0159, an inhibitor of the KIT receptor, led to sustained reductions in plasma tryptase levels in the phase 1 trial.
Allergy & Asthma
Dupilumab for Eosinophilic Esophagitis: “Pivotal Data” in Phase 3 Trial
Dupixent (dupilumab), developed by Regeneron and Sanofi, has shown “significant efficacy” for Eosinophilic Esophagitis in a phase 3 trial.
Eczema Treatment in Adults: Latest Research and Medications
Everything that you should know about the treatment of eczema in adults, including the latest research, medications, and recommendations.
Folic Acid Levels At Birth Associated with Onset of Childhood Food Allergies
A recent study involving the Boston Birth Cohort associated concentrations of folic acid levels at birth with the development of food allergies during childhood.
Childhood Food Allergy Diagnoses Associated with Prescription Antibiotic Use
Childhood food allergy diagnoses have been associated with the use of prescription antibiotics during the first year of life.
Safe and Effective Immunotherapy for Allergy to Common Fungus
Subcutaneous allergen immunotherapy has been demonstrated to be a safe and effective treatment for individuals allergic to a common fungus.